Prot# SHH4429g: A Randomized, Placebo-Controlled Phase II Study of GDC-0449 (Systemic Hedgehog Antagonist) with Concurrent Chemotherapy and Bevacizumab as First-Line Therapy for Metastatic Colorectal Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date1/27/097/27/13

Funding

  • Genentech, Inc. (SHH4429g)